{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11302563", "DateCompleted": {"Year": "2001", "Month": "08", "Day": "09"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0176-3679", "JournalIssue": {"Volume": "34", "Issue": "2", "PubDate": {"Year": "2001", "Month": "Mar"}}, "Title": "Pharmacopsychiatry", "ISOAbbreviation": "Pharmacopsychiatry"}, "ArticleTitle": "Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum.", "Pagination": {"StartPage": "45", "EndPage": "49", "MedlinePgn": "45-9"}, "Abstract": {"AbstractText": ["Hypericum perforatum is considered an effective alternative to the synthetic antidepressants in the treatment of mild-to-moderate depression. Recently, we showed that the effects on neurotransmitter contents in different brain regions of laboratory animals are more evident after administration of hypericum extracts containing a higher concentration of flavonoids, thus suggesting that these compounds are important in the antidepressant action of hypericum perforatum. We studied the effects of Ph-50, a hypericum extract standardized to flavonoids (50%) and containing 0.3% hypericin and 4.5% hyperforin on brain serotonin content, norepinephrine and dopamine by a high-performance liquid chromatography method in discrete brain areas (cortex, diencephalon and brainstem) in male Sprague-Dawley rats. Moreover, we evaluated the effects of Ph-50 alone or in association with sulpiride (a dopamine receptor antagonist), metergoline (a serotonin receptor antagonist) and 6-hydroxydopamine (6-OH-DA, destroying norepinephrine-containing neurons) using a forced-swimming test in the rat. Hypericum extract (Ph-50; 250-500 mg/kg) with acute oral administration enhanced serotonin, norepinephrine and dopamine content in the brain and reduced the immobility time of rats in the forced-swimming test. Sulpiride, metergoline and 6-OH-DA significantly increased the period of immobility in the forced-swimming test for the rats receiving hypericum extract (Ph-50). The results indicate that the neurotransmitters studied could be involved in the anti-immobility effects of hypericum, and suggest that its antidepressant action is probably mediated by serotonergic, noradrenergic and dopaminergic system activation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacology, School of Medicine, University of Messina, Torre Biologica Policlinico Universitario, Italy. gcalapai@unime.it"}], "Identifier": [], "LastName": "Calapai", "ForeName": "G", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Crupi", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Firenzuoli", "ForeName": "F", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Inferrera", "ForeName": "G", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Squadrito", "ForeName": "F", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Parisi", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "De Sarro", "ForeName": "G", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Caputi", "ForeName": "A", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Pharmacopsychiatry", "NlmUniqueID": "8402938", "ISSNLinking": "0176-3679"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents, Second-Generation"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "333DO1RDJY", "NameOfSubstance": "Serotonin"}, {"RegistryNumber": "54-16-0", "NameOfSubstance": "Hydroxyindoleacetic Acid"}, {"RegistryNumber": "7MNE9M8287", "NameOfSubstance": "Sulpiride"}, {"RegistryNumber": "8HW4YBZ748", "NameOfSubstance": "Oxidopamine"}, {"RegistryNumber": "VTD58H1Z2X", "NameOfSubstance": "Dopamine"}, {"RegistryNumber": "X4W3ENH1CV", "NameOfSubstance": "Norepinephrine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antidepressive Agents, Second-Generation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Brain Chemistry"}, {"QualifierName": ["psychology"], "DescriptorName": "Depression"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dopamine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hydroxyindoleacetic Acid"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Norepinephrine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxidopamine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serotonin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulpiride"}, {"QualifierName": ["psychology"], "DescriptorName": "Swimming"}, {"QualifierName": [], "DescriptorName": "Sympathectomy, Chemical"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "4", "Day": "17", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "8", "Day": "10", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "4", "Day": "17", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11302563", "10.1055/s-2001-15180"]}}], "PubmedBookArticle": []}